APA (7th ed.) Citation

Gelaye, A. T., Seid, M. A., & Baffa, L. D. (2022). Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia. Vascular health and risk management, 18, 481-493. https://doi.org/10.2147/VHRM.S363051

Chicago Style (17th ed.) Citation

Gelaye, Abebech Tewabe, Mohammed Assen Seid, and Lemlem Daniel Baffa. "Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia." Vascular Health and Risk Management 18 (2022): 481-493. https://doi.org/10.2147/VHRM.S363051.

MLA (9th ed.) Citation

Gelaye, Abebech Tewabe, et al. "Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia." Vascular Health and Risk Management, vol. 18, 2022, pp. 481-493, https://doi.org/10.2147/VHRM.S363051.